Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-17

Clinical Trial Update: Isoleucine Added ORS in Children With Diarrhoea [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated adding the amino acid isoleucine to oral rehydration solution in children with acute infectious diarrhoea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoleucine added ORS (isoleucine)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Acute Infectious Diarrhoea in Children | Phase 2 | Status: COMPLETED